À proposConditionsConfidentialitéContact
 
Actualisation
On The Pen: The Weekly Dose

On The Pen: The Weekly Dose

Dave Knapp Man On The Mounjaro
Date de sortie : 2024-05-25
© 2024 On The Pen: The Weekly Dose
On The Pen: The Weekly Dose - QR Code
LibreNew
28 épisodes
Audio
Écouter sur Apple Podcasts
LibreNew
28 épisodes
Audio
Écouter sur Apple Podcasts
Date de sortie : 2024-05-25
© 2024 On The Pen: The Weekly Dose
L’épisode le plus récent
On The Pen Live Eps 67: Survodutide Trial Participant Tells All!

On The Pen Live Eps 67: Survodutide Trial Participant Tells All!

Durée : 1:17:41
Lecture
Send us a Text Message.In this week’s episode of On The Pen Live, guest Scott Liberto of PlanetScott.com joins to discuss his experience in the Survodutide clinical trial.Survodutide is an investigational dual agonist targeting both the glucagon and GLP-1 receptors, developed by Boehringer Ingelheim in collaboration with Zealand Pharma. This novel drug is designed to treat obesity and metabolic dysfunction-associated steatohepatitis (MASH). Support the Show.MY WORK RELIES ON YOUR GENEROS...
Id. d’épisode : 1000656746120
GUID : Buzzsprout-15135118
Date de publication : 25/5/2024 à 19:00:00

Description

Dave Knapp brings you your weekly dose of everything in the news about incretin mimetic, diabetes and obesity therapies, like Zepbound and Mounjaro, Ozempic and Wegovy, and even investigational treatments like CagriSema and Retatrutide!

Adresse du flux

https://feeds.buzzsprout.com/2302090.rss

Apple Podcasts : Avis des utilisateurs

Pas d'entrée